Agilent Completes Acquisition of Lasergen, Inc. SANTA CLARA, Calif., May 7, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has completed the acquisition of Lasergen, Inc. (Lasergen), an emerging biotechnology company focused on research and development of innovative technologies for DNA sequencing. In March 2016 Agilent made an initial investment in the Houston,... Read more
Agilent Expands Logistics Center in Texas Construction Anticipates Future Growth in Genomics Market SANTA CLARA, Calif., May 4, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it is breaking ground on a 15,000-square-foot expansion of the company’s logistics center in Cedar Creek, Texas. The expansion will increase Agilent’s capacity to house inventory to fulfill... Read more
Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm Acquisition will enable Agilent to provide a single informatics solution across laboratory and operational domains SANTA CLARA, Calif., May 2, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held Genohm, a developer of highly differentiated,... Read more
Agilent Announces Real-Time, Live-Cell ATP Rate Assay Kit New Assay Expands Application Range of Agilent Seahorse XF Technology SANTA CLARA, Calif., May 1, 2018 Agilent Technologies Inc. (NYSE: A) today announced the Agilent Seahorse XF Real-Time ATP Rate Assay Kit, a new product that will enable biologists to enhance their understanding of how live-cells function... Read more
Agilent Opens Global Solution Development Center in Singapore Laboratory Designed to Meet Demand for Fully Tested Solutions in Pharma, Biopharma and Food Analysis SANTA CLARA, Calif., April 27, 2018 Agilent Technologies Inc. (NYSE: A) today opened a new facility in Singapore dedicated to developing integrated end-to-end workflows across a range of disciplines, including pharma, biopharma,... Read more
Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing Fully automated CISH and IQFISH panel for lymphoma combines multiple innovations SANTA CLARA, Calif., April 26, 2018 Agilent Technologies Inc. (NYSE: A) today announced an expansion of its portfolio of in situ hybridization probes with the release of its EBER RNA CISH, Kappa, and... Read more
Agilent Thought Leader Award Presented to Drs. Brandon Ruotolo and Kristina Hakansson University of Michigan scientists recognized for research in advanced methods for characterization of proteins and protein complexes SANTA CLARA, Calif., April 25, 2018 Agilent Technologies Inc. (NYSE: A) today announced that two leading scientists at the University of Michigan—Brandon Ruotolo and Kristina Hakansson—have... Read more
Agilent Announces Executive Appointments SANTA CLARA, Calif., April 24, 2018 Highlights: Jacob Thaysen named President, Life Sciences and Applied Markets Group, moving from Agilent’s Diagnostics and Genomics Group Sam Raha appointed President, Diagnostics and Genomics Group, moving from Agilent Strategy and Corporate Development Agilent Technologies Inc. (NYSE: A) today announced that Jacob Thaysen, currently, senior... Read more
Agilent Announces Departure of Patrick Kaltenbach SANTA CLARA, Calif., April 16, 2018 Agilent Technologies Inc. (NYSE: A) today announced that Patrick Kaltenbach, senior vice president, Agilent and president, Life Sciences and Analytical Group (LSAG), will leave the company on April 20, 2018. A replacement process for Kaltenbach’s position is underway, drawing on Agilent’s deep internal... Read more
Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018 SANTA CLARA, Calif., April 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its line-up of innovative solutions for laboratory efficiency at Analytica, being held April 10 – 13, in Munich, Germany. This year at the 26th international trade fair for... Read more